Insider Sell: EVP, GC & Corporate Secretary Delano Ladd Sells 2,499 Shares of HealthEquity ...
On February 9, 2024, Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity Inc (HQY), sold 2,499 shares of the company. The transaction was filed with the SEC and can be found through this SEC Filing.
HealthEquity Inc is a company that provides technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Their platform offers solutions for health savings accounts (HSAs), health reimbursement arrangements (HRAs), and other related services, facilitating the management of healthcare expenses for individuals and employers.
Over the past year, the insider has sold a total of 5,085 shares and has not made any purchases of the company's stock.
The insider transaction history for HealthEquity Inc shows a pattern of 0 insider buys and 13 insider sells over the past year.
On the day of the insider's recent sell, shares of HealthEquity Inc were trading at $80, giving the company a market cap of $6.831 billion.
The price-earnings ratio of HealthEquity Inc stands at 235.53, which is significantly higher than the industry median of 26.61 and also above the company's historical median price-earnings ratio.
With a trading price of $80 and a GuruFocus Value of $75.90, HealthEquity Inc has a price-to-GF-Value ratio of 1.05, indicating that the stock is Fairly Valued according to the GF Value metric.
The GF Value is calculated considering historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates provided by Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
